Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase-activated protein kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | MAP kinase activated protein kinase 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Schistosoma japonicum | ko:K04443 mitogen-activated protein kinase-activated protein kinase 2, putative | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Brugia malayi | map kinase activated protein kinase protein 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Schistosoma mansoni | serine/threonine protein kinase | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase-activated protein kinase 2 | 370 aa | 303 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0217 | 1 | 1 |
Onchocerca volvulus | Alhambra homolog | 0.0031 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0031 | 0 | 0.5 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0031 | 0 | 0.5 |
Schistosoma mansoni | jumonji domain containing protein | 0.0081 | 0.2685 | 0.2685 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 0.8065 | 0.8065 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 0.8065 | 0.8065 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0038 | 0.0353 | 0.0353 |
Echinococcus granulosus | geminin | 0.0181 | 0.8065 | 0.8065 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.0217 | 1 | 1 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0038 | 0.0353 | 0.0353 |
Brugia malayi | jmjC domain containing protein | 0.0102 | 0.3813 | 0.3813 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0038 | 0.0353 | 0.0353 |
Plasmodium falciparum | phd finger protein, putative | 0.0031 | 0 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0038 | 0.0353 | 0.0353 |
Echinococcus multilocularis | geminin | 0.0181 | 0.8065 | 0.8065 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0102 | 0.3813 | 0.3813 |
Brugia malayi | jmjC domain containing protein | 0.0038 | 0.0353 | 0.0353 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.0217 | 1 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0038 | 0.0353 | 0.0353 |
Giardia lamblia | PHD finger protein 15 | 0.0031 | 0 | 0.5 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.0217 | 1 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0102 | 0.3813 | 0.3813 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1197 | 0.1197 |
Echinococcus granulosus | jumonji domain containing protein | 0.0043 | 0.0656 | 0.0656 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0043 | 0.0656 | 0.0656 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0064 | 0.1784 | 0.1784 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0031 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 2400 nM | Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins | ChEMBL. | 24900435 |
IC50 (binding) | = 70 nM | Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP | ChEMBL. | 24900435 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.